Linked Life Data

15673801

Source:http://linkedlifedata.com/resource/pubmed/id/15673801

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2005-1-27
pubmed:abstractText
The majority of patients with Wegener's granulomatosis have disease flares after conventional medications are tapered. There is no consistently safe, effective treatment for the maintenance of remission.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2005 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
352
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
351-61
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15673801-Cyclophosphamide, pubmed-meshheading:15673801-Double-Blind Method, pubmed-meshheading:15673801-Drug Therapy, Combination, pubmed-meshheading:15673801-Female, pubmed-meshheading:15673801-Glucocorticoids, pubmed-meshheading:15673801-Humans, pubmed-meshheading:15673801-Immunoglobulin G, pubmed-meshheading:15673801-Immunosuppressive Agents, pubmed-meshheading:15673801-Male, pubmed-meshheading:15673801-Methotrexate, pubmed-meshheading:15673801-Middle Aged, pubmed-meshheading:15673801-Neoplasms, pubmed-meshheading:15673801-Proportional Hazards Models, pubmed-meshheading:15673801-Receptors, Tumor Necrosis Factor, pubmed-meshheading:15673801-Recurrence, pubmed-meshheading:15673801-Remission Induction, pubmed-meshheading:15673801-Treatment Failure, pubmed-meshheading:15673801-Tumor Necrosis Factor-alpha, pubmed-meshheading:15673801-Wegener Granulomatosis
pubmed:year
2005
pubmed:articleTitle
Etanercept plus standard therapy for Wegener's granulomatosis.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Multicenter Study